2015 Clinic IT Patient-Centered 
The Medical Futurist
JUNE 21, 2025
The California-based firm, Second Sight , the German company, Retina Implant AG, and the French venture, Pixium Vision were the forerunners of the field, developing implantable visual prosthetics to restore vision to patients who are blind as a result of the rare condition of retinitis pigmentosa. How far can you see and hear? Globally 1.1
The Clinical Problem Solvers
SEPTEMBER 19, 2024
Describe the positive impacts of qualitative methods on healthcare provision and/or policies in clinical settings. She has advanced training in Quality Improvement and Patient Safety Science. She has advanced training in Quality Improvement and Patient Safety Science. During this episode, we hear from Dr. S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Louisville Lectures
MAY 5, 2023
Boot Camp: PHASE TWO Or, Emergencies and Assessing Them This week, we will look at two highly anticipated videos, Electrolyte Emergencies by Dr. Eleanor Lederer and Assessing the Seriously Ill Patient by Dr. David Nunley. Are you a resident or medical student looking to learn practical, evidence based approaches to your patients?
The Clinical Problem Solvers
JUNE 26, 2023
Dr. Saha’s research focuses broadly on the influence of race and racism in the doctor-patient relationship, its relation to disparities in the quality of health care, and its implications for diversity in the healthcare workforce. He subsequently worked at OHSU and the Portland VA for 2 decades before moving to Johns Hopkins University.
PEMBlog
JUNE 14, 2023
This episode is a co-production of the Emergency Medical Services for Children Innovation and Improvement Center whose mission is to minimize morbidity and mortality of acutely ill and injured children across the emergency continuum. It is also the final episode in a 5 episode series focused on agitation in children and adolescents.
FDA Law Blog
JUNE 23, 2021
Valentine — For the last 13 years, this blogger has been at the center of what has now been dubbed “patient-focused drug development.” For 6 years, I served as a patient liaison within FDA in what was then called the Office of Special Health Issues. By James E. The practice of medicine was viewed as paternalistic.
FDA Law Blog
NOVEMBER 1, 2023
Regulating LDTs: A Long and Winding Road In what might sound to some like protesting too much, the PR invokes FDA’s longstanding assertion that IVDs “manufactured” by laboratories are medical devices and that clinical laboratories that develop tests are acting as manufacturers.
Expert insights. Personalized for you.
98 
Let's personalize your content